```json
{
"content": [
{
"type": "paragraph",
"content": "North America dominates the Anti-tetanus Immunoglobulin market growth, holding a 35% regional share, driven by advanced healthcare infrastructure, high vaccination adoption rates, and stringent regulatory frameworks like the FDA’s post-exposure prophylaxis guidelines. Robust R&D investments and a mature ecosystem further solidify its leadership."
},
{
"type": "paragraph",
"content": "Europe follows with a 25% share, supported by mature healthcare systems, strong public health policies, and EU-wide immunization programs. The region’s emphasis on rapid diagnostic adoption and cross-border collaboration enhances market stability, though growth is tempered by saturated markets."
},
{
"type": "paragraph",
"content": The Asia Pacific region emerges as the fastest-growing market, capturing 20% in 2023. Drivers include rising awareness, expanding healthcare access in emerging economies like India and China, and government initiatives to strengthen vaccination coverage. Demographic pressure and urbanization are accelerating demand for cost-effective therapies."
},
{
"type": "paragraph",
"content": "Latin America (15%) and the Middle East & Africa (5%) exhibit uneven adoption due to fragmented healthcare infrastructure and economic disparities. However, Latin America benefits from regional partnerships, while the Middle East sees incremental growth from private-sector investments in vaccine logistics."
}
],
"worldMapData": {
"regions": [
{ "name": "North America", "value": 35 },
{ "name": "Europe", "value": 25 },
{ "name": "Asia Pacific", "value": 20 },
{ "name": "Latin America", "value": 15 },
{ "name": "Middle East & Africa", "value": 5 }
]
}
}
```
